Mal-PEG8-Val-Ala-Exatecan
Mal-PEG8-Val-Ala-Exatecan (Compound 1033) is a Drug-Linker Conjugates for ADC, which is composed of Exatecan (HY-13631) and a linker. Mal-PEG8-Val-Ala-Exatecan can be used for ADC synthesis[1].
Product Specifications
CAS Number
[3025787-70-3]
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C5C6=C(CC[C@@H]5NC([C@H](C)NC([C@H](C(C)C)NC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCN7C(C=CC7=O)=O)=O)=O)=O)=O)C(C)=C(F)C=C6N=C4C3=C2)=O
Molecular Formula
C58H78FN7O18
Molecular Weight
1180.27
References & Citations
[1]Jaume Pons, et al. Exatecan derivatives and antibody-drug conjugates thereof. Patent. WO2024098066
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15132324 1 Vial
Lentiviral human SLC13A5 shRNA (UAS) - Lentiviral human SLC13A5 shRNA (UAS, RFP) (100)
Ask
View Details 